ECHEMI KOREA was successfully established, a new milestone towards globalization

On November 9, 2023, ECHEMI KOREA CO., LTD (hereinafter referred to as ECHEMI KOREA) was officially established, which means that ECHEMI's internationalization strategy has taken another big step forward.

ECHEMI KOREA will take the Pharmaceutical business as the first stop of its core business, based on the needs of customers for preparations, APIs, intermediates and pharmaceutical excipients, unite excellent pharmaceutical suppliers around the world, provide product registration, auditing, License In/Out, technology transfer and other services, provide global suppliers with complete marketing solutions, and provide customers with better products and services.

Mr. Charlie, the country manager of ECHEMI KOREA, is Korean. With more than 20 years of experience in the Korean pharmaceutical market, Charlie is good at promoting and selling pharmaceutical APIs, intermediates and preparations in the Korean market. He is familiar with the regulations of the Korean market and has led the registration team to successfully register dozens of API products with KFDA. He has had successful cooperation experience with well-known pharmaceutical suppliers in China, India and Europe, helping many Chinese suppliers complete KDMF registration and successfully introducing many Chinese products into the Korean market. After joining ECHEMI, Charlie will lead ECHEMI's sales team, registration team and sourcing team, and continue to provide services and products to suppliers and customers.

As ECHEMI CEO David Zhang said: "The formal establishment of ECHEMI Korea is an important step for ECHEMI's internationalization and localization. Mr. Charlie's joining will lead the Korean team to a higher level in terms of service speed and quality."

ECHEMI Korea's office is located at: 326 Wangsimni-ro, Seongdong-gu, Seoul, Korea. Suppliers and customers are welcome to visit and negotiate.